These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

480 related articles for article (PubMed ID: 30240805)

  • 21. Comparing myelin-sensitive magnetic resonance imaging measures and resulting g-ratios in healthy and multiple sclerosis brains.
    Berg RC; Menegaux A; Amthor T; Gilbert G; Mora M; Schlaeger S; Pongratz V; Lauerer M; Sorg C; Doneva M; Vavasour I; Mühlau M; Preibisch C
    Neuroimage; 2022 Dec; 264():119750. PubMed ID: 36379421
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessing the differential sensitivities of wave-CAIPI ViSTa myelin water fraction and magnetization transfer saturation for efficiently quantifying tissue damage in MS.
    Elkady AM; Wu Z; Leppert IR; Arnold DL; Narayanan S; Rudko DA
    Mult Scler Relat Disord; 2021 Nov; 56():103309. PubMed ID: 34688179
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perilesional neurodegenerative injury in multiple sclerosis: Relation to focal lesions and impact on disability.
    Clarke MA; Lakhani DA; Wen S; Gao S; Smith SA; Dortch R; Xu J; Bagnato F
    Mult Scler Relat Disord; 2021 Apr; 49():102738. PubMed ID: 33609957
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myelin Quantification in White Matter Pathology of Progressive Multiple Sclerosis Post-Mortem Brain Samples: A New Approach for Quantifying Remyelination.
    Huitema MJD; Strijbis EMM; Luchicchi A; Bol JGJM; Plemel JR; Geurts JJG; Schenk GJ
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884445
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Global loss of myelin water over 5 years in multiple sclerosis normal-appearing white matter.
    Vavasour IM; Huijskens SC; Li DK; Traboulsee AL; Mädler B; Kolind SH; Rauscher A; Moore GW; MacKay AL; Laule C
    Mult Scler; 2018 Oct; 24(12):1557-1568. PubMed ID: 28782447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of a Multiparametric Quantitative MRI Model That Assesses Myelin and Edema for Evaluating Plaques, Periplaque White Matter, and Normal-Appearing White Matter in Patients with Multiple Sclerosis: A Feasibility Study.
    Hagiwara A; Hori M; Yokoyama K; Takemura MY; Andica C; Kumamaru KK; Nakazawa M; Takano N; Kawasaki H; Sato S; Hamasaki N; Kunimatsu A; Aoki S
    AJNR Am J Neuroradiol; 2017 Feb; 38(2):237-242. PubMed ID: 27789453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multiple sclerosis plaques may undergo continuous myelin degradation: a cross-sectional study with myelin and axon-related quantitative magnetic resonance imaging metrics.
    Maekawa T; Hagiwara A; Yokoyama K; Hori M; Andica C; Fujita S; Kamagata K; Wada A; Abe O; Tomizawa Y; Hattori N; Aoki S
    Neuroradiology; 2022 Mar; 64(3):465-471. PubMed ID: 34383123
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deep learning of joint myelin and T1w MRI features in normal-appearing brain tissue to distinguish between multiple sclerosis patients and healthy controls.
    Yoo Y; Tang LYW; Brosch T; Li DKB; Kolind S; Vavasour I; Rauscher A; MacKay AL; Traboulsee A; Tam RC
    Neuroimage Clin; 2018; 17():169-178. PubMed ID: 29071211
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Myelin Imaging in Human Brain Using a Short Repetition Time Adiabatic Inversion Recovery Prepared Ultrashort Echo Time (STAIR-UTE) MRI Sequence in Multiple Sclerosis.
    Ma YJ; Jang H; Wei Z; Cai Z; Xue Y; Lee RR; Chang EY; Bydder GM; Corey-Bloom J; Du J
    Radiology; 2020 Nov; 297(2):392-404. PubMed ID: 32779970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Brain tissue and myelin volumetric analysis in multiple sclerosis at 3T MRI with various in-plane resolutions using synthetic MRI.
    Saccenti L; Andica C; Hagiwara A; Yokoyama K; Takemura MY; Fujita S; Maekawa T; Kamagata K; Le Berre A; Hori M; Hattori N; Aoki S
    Neuroradiology; 2019 Nov; 61(11):1219-1227. PubMed ID: 31209528
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Three-Dimensional Lesion Phenotyping and Physiologic Characterization Inform Remyelination Ability in Multiple Sclerosis.
    Sivakolundu DK; Hansen MR; West KL; Wang Y; Stanley T; Wilson A; McCreary M; Turner MP; Pinho MC; Newton BD; Guo X; Rypma B; Okuda DT
    J Neuroimaging; 2019 Sep; 29(5):605-614. PubMed ID: 31148298
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of multiple sclerosis neuroinflammation and neurodegeneration with relaxation and diffusion basis spectrum imaging.
    Vavasour IM; Sun P; Graf C; Yik JT; Kolind SH; Li DK; Tam R; Sayao AL; Schabas A; Devonshire V; Carruthers R; Traboulsee A; Moore GW; Song SK; Laule C
    Mult Scler; 2022 Mar; 28(3):418-428. PubMed ID: 34132126
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myelin Measurement Using Quantitative Magnetic Resonance Imaging: A Correlation Study Comparing Various Imaging Techniques in Patients with Multiple Sclerosis.
    Saccenti L; Hagiwara A; Andica C; Yokoyama K; Fujita S; Kato S; Maekawa T; Kamagata K; Le Berre A; Hori M; Wada A; Tateishi U; Hattori N; Aoki S
    Cells; 2020 Feb; 9(2):. PubMed ID: 32046340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparing MRI metrics to quantify white matter microstructural damage in multiple sclerosis.
    Lipp I; Jones DK; Bells S; Sgarlata E; Foster C; Stickland R; Davidson AE; Tallantyre EC; Robertson NP; Wise RG; Tomassini V
    Hum Brain Mapp; 2019 Jul; 40(10):2917-2932. PubMed ID: 30891838
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High field MRI correlates of myelin content and axonal density in multiple sclerosis--a post-mortem study of the spinal cord.
    Mottershead JP; Schmierer K; Clemence M; Thornton JS; Scaravilli F; Barker GJ; Tofts PS; Newcombe J; Cuzner ML; Ordidge RJ; McDonald WI; Miller DH
    J Neurol; 2003 Nov; 250(11):1293-301. PubMed ID: 14648144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter.
    Narayanan S; Francis SJ; Sled JG; Santos AC; Antel S; Levesque I; Brass S; Lapierre Y; Sappey-Marinier D; Pike GB; Arnold DL
    Neuroimage; 2006 Jan; 29(2):637-42. PubMed ID: 16126413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differentiation and quantification of inflammation, demyelination and axon injury or loss in multiple sclerosis.
    Wang Y; Sun P; Wang Q; Trinkaus K; Schmidt RE; Naismith RT; Cross AH; Song SK
    Brain; 2015 May; 138(Pt 5):1223-38. PubMed ID: 25724201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diffusivity in multiple sclerosis lesions: At the cutting edge?
    Klistorner A; Wang C; Fofanova V; Barnett MH; Yiannikas C; Parratt J; You Y; Graham SL
    Neuroimage Clin; 2016; 12():219-26. PubMed ID: 27489769
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Permanent tissue damage in multiple sclerosis lesions is associated with reduced pre-lesion myelin and axon volume fractions.
    Tagge IJ; Leppert IR; Fetco D; Campbell JS; Rudko DA; Brown RA; Stikov N; Pike GB; Giacomini PS; Arnold DL; Narayanan S
    Mult Scler; 2022 Nov; 28(13):2027-2037. PubMed ID: 35903888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative evaluation of cerebral white matter in patients with multiple sclerosis using multicomponent T2 mapping.
    Baranovicova E; Mlynarik V; Kantorova E; Hnilicova P; Dobrota D
    Neurol Res; 2016 May; 38(5):389-96. PubMed ID: 27078709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.